M. Gama is Associate Professor with Habillitation at the University of Minho and head of the research group FUNCARB, from the Center of Biological Engineering.  Has been Director of the Integrated Masters on Biomedical Engineering (2006-08; 2012-14) and of the PhD program on Biomedical Engineering (2017-18), Coordinator of the Clinical Engineering branch of the Biomedical Engineering Integrated Master program (2006-2012) and Vice-Director of the Centre of Biological Engineering (2016-20). Is responsible for teaching courses on Physical Chemistry, Interfacial Phenomena, Enzyme Technology, Biocompatibility and Controlled Drug Release. Miguel Gama published 190 papers registered on Scopus, with an h-index 44 (h-index 52 on Google Academics). Successfully supervised 22 completed PhD thesis (3 more ongoing). Has been the (main or local) coordinator of 13 research projects (FCT, Euronanomed, FP6, FP7) and integrated the team of 10 other projects, corresponding to a fund raising of 2.3M¿. Member of the Editorial board of the journal Nanomaterials. Inventor of 2 patents, one related to an injectable hydrogel for bone regeneration (recently tested for maxilofacial applications in clinical assays), another one related to dry powdered formulations of bacterial cellulose for cosmetic and food applications. M. Gama is an experienced scientist in the field of BC: editor of 2 books on Bacterial NanoCellulose (by CRC Press and Elsevier), and organizer of several editions of the International Symposium on Bacterial NanoCellulose (previous editions in New Orleans, 2013; Gdansk, 2015; Fukuoka, 2017; Porto, 2019; Jena, 2022). The next Symposium will be held in Shanghai, 2024. Together with the Co-PI, M. Gama founded Satisfibre, S.A., a UMinho spin-off, aiming at R&D activities, production & commercialization of BC-based products for several market applications. Within the activities of Satisfibre, which started in 2013 , a technology for the large scale production of BC was developed. This technology was initially developed at lab scale, then demonstrated at pilot scale using facilities and equipment hired for that purpose (at Bodec, Holland). These assays were successful. In collaboration with JPM Industry, a PT company with expertise in Project Engineering, the detailed layout of the production facility was designed, allowing the estimation of CAPEX and OPEX costs, including land, buildings, equipment, human resources, water and energy, waste water treatment, etc. Based on this information, a production cost was estimated for different production scales. This technology is Satisfibre´s industrial secret. At the same time, a dry formulation of BC, a product aimed for cosmetic and food applications (as a stabilizer of emulsions and texturizing additive) was developed. This product formulation was patented worldwide (WO 2020/136629). The assets developed by Satisfibre are drawing the interest of several  international companies and negotiations are ongoing with regards to its appreciation, potential partnerships/licencing.